60% is a key intermediate in clinic or close to clinic, which has predictable market value.
20% are products with good market prospects and suitable for proprietary technology in Xianghai.
20% are products used for clinical new drug research and development in cooperation with large pharmaceutical companies.
Research and development institutions
The company has established a provincial-level R&D center for high-tech enterprises approved by the Science and Technology Department of Zhejiang Province, an enterprise postdoctoral research center approved by the Personnel Department of Zhejiang Province, and a chiral drug pilot base of the National New Drug Development Engineering Technology Research Center.
The company has set up a special research center to be responsible for product research and development. The research center has a team of high-quality expert consultants and a group of experienced R&D personnel, including six R&D departments, 1 multi-functional pilot plant (including catalytic hydrogenation room) and 1 anhydrous and anaerobic ultra-low temperature workshop. The research center has developed chiral chemistry, catalytic hydrogenation, low temperature reaction, butyl lithium reaction, triethylboron-sodium borohydride reduction, ozone oxidation and other characteristic technologies. It has special reaction equipment such as anhydrous anaerobic low-temperature reaction, ozone oxidation, pressurized catalytic hydrogenation, membrane separation and concentration, resin separation and purification, aseptic freeze-drying crystallization and so on.
Joint/cooperative/collaborative development
The company has established long-term cooperative relations with National New Drug Development Engineering Technology Research Center, China Academy of Medical Sciences, Beijing Institute of Pharmacy, Shanghai Institute of Organic Chemistry of Chinese Academy of Sciences, China Pharmaceutical University, Beijing Military Medical College, Zhejiang University, chongqing medical Institute of Engineering, Chengdu Institute of Organic Science of China Academy of Sciences, Shanghai Institute of Medical Engineering, Zhejiang University of Technology and other units, and built a research and development base combining scientific research institutions with the company's laboratory. Through close cooperation with scientific research institutions, the company can timely capture the information and technology of global new drug products and promote the industrialization of scientific research results.